Progress using Tc-99m radiopharmaceuticals for measuring high capacity sites and low density sites

Drug Discovery Today

Volumn 18, Issue 19-20, 2013, Pages 984-991

  Eckelman, William C ^a   Jones, Alun G ^b   Duatti, Adriano ^c   Reba, Richard C ^d  

^a Molecular Tracer LLC   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF FERRARA   (Italy)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

[2 [[2 [[[3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCT 2 YL]METHYL](2 MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOLATO]OXOTECHNETIUM TC 99M; CHELATE; CYSTEINE ETHYL ESTER TC 99M; DEPREOTIDE TC 99M; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; MERTIATIDE TC 99M; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MOLYBDENUM 99; RADIOPHARMACEUTICAL AGENT; TEBOROXIME TC 99M; TECHNETIUM 99M; TETROFOSMIN TC 99M; TILMANOCET TC 99M; UNCLASSIFIED DRUG;

BRAIN; COMPUTER PROGRAM; HEART; HUMAN; KIDNEY; LIVER; MEDICAL DEVICE; NONHUMAN; PROTEIN EXPRESSION; RADIATION ATTENUATION; RADIATION MEASUREMENT; RADIATION SCATTERING; RADIOCHEMISTRY; REVIEW;

ANIMALS; HUMANS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TECHNETIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84884591283     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2013.06.008     Document Type: Review

References (59)

1. W.C. Eckelman Targeted imaging: an important biomarker for understanding disease progression in the era of personalized medicine Drug Discov. Today 13 2008 748 759
2. A.P. Wolf Synthesis of radiopharmaceuticals and labelled compounds using short-lived isotopes Radiopharmaceuticals and Labelled Compounds 1973 IAEA 345 351
3. W.C. Eckelman A nuclear medicine odyssey U. Mazzi, Proceedings of the Seventh International Symposium on Technetium, Rhenium and Other Metals in Chemistry and Nuclear Medicine 2002 Servizi Grafici Editoriali snc pp. XLVII-LII
4. E. Segre The adventurous history of the discovery of technetium M. Nicolini, Technetium in Chemistry and Nuclear Medicine 1986 Raven Press 1 10
5. E. Segre, and G.T. Seaborg Nuclear isomerism in element 43 Phys. Rev. 54 1938 772
6. P. Richards Technetium-99m: the early days U. Mazzi, Proceedings of the Seventh International Symposium on Technetium, Rhenium and Other Metals in Chemistry and Nuclear Medicine 1990 Servizi Grafici Editoriali snc 1 9
7. P. Richards A survey of the production at Brookhaven National Laboratory of radioisotopes for medical research VII Rassegna Internazionale Electronica e Nucleare Rome 1960 223 244
8. M.M. Ter-Pogossian, and H.N. Wagner Jr. A new look at the cyclotron for making short-lived isotopes Semin. Nucl. Med. 28 1998 202 212
9. P. Ritt Absolute quantification in SPECT Eur. J. Nucl. Med. Mol. Imaging 38 2011 S69 S77
10. 18F]FDG for use in oncology and neurosciences Nucl. Med. Biol. 37 2010 727 740
11. S.M. Qaim Development of novel positron emitters for medical applications: nuclear and radiochemical aspects Radiochim. Acta 99 2011 611 625
12. A. Duatti Nonisotopic substitution. Is fluorine a replacement for hydrogen? Nucl. Med. Biol. 2013 (accepted; uncorrected proof)
13. K.A. Krohn True tracers: comparing FDG with glucose and FLT with thymidine Nucl. Med. Biol. 32 2005 663 671 (Pubitemid 41502970)
14. R.R. Raylman Capabilities of two- and three-dimensional FDG-PET for detecting small lesions and lymph nodes in the upper torso: a dynamic phantom study Eur. J. Nucl. Med. 26 1999 39 45 (Pubitemid 29137737)
15. A. Afshar-Oromieh PET imaging with a [(68)Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions Eur. J. Nucl. Med. Mol. Imaging 40 2013 797 798
16. M. Schäfer A dimerized urea-based inhibitor of the prostate-specific membrane antigen for 68Ga-PET imaging of prostate cancer Eur. J. Nucl. Med. Mol. Imaging 2 2012 223
17. D.L. Bailey, and K.P. Willowson An evidence-based review of quantitative SPECT imaging and potential clinical applications J. Nucl. Med. 54 2013 83 89
18. Common names for radiopharmaceuticals were used in this section. Other acronyms, the IUPAC chemical name and drawings of some chemical structures are contained in Table 1 and Box 1.
19. W.C. Eckelman, and P. Richards Instant 99m-Tc-DTPA J. Nucl. Med. 11 1970 761
20. B.L. Holman A new Tc-99m labeled myocardial imaging agent, hexakis (tbutylisonitrile)-technetium (I) (Tc-99m TBI). Initial experience in the human J. Nucl. Med. 25 1984 1350 1355 (Pubitemid 15222880)
21. J.D. Kelly Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging J. Nucl. Med. 34 1993 222 227 (Pubitemid 23056400)
22. R.K. Narra A neutral 99mTc complex for myocardial imaging J. Nucl. Med. 30 1989 1830 1837
23. X. Niu Comparison study of temporal regularization methods for fully 5D reconstruction of cardiac gated dynamic SPECT Phys. Med. Biol. 7 2012 5523 5542
24. D.W. Seldin Myocardial perfusion imaging with technetium-99m SQ 30217: comparison with thallium-201 and coronary anatomy J. Nucl. Med. 30 1989 312 319 (Pubitemid 19077320)
25. H. Gewirtz Differential myocardial washout of technetium-99m teboroxime: mechanism and significance J. Nucl. Med. 32 1992 2009 2011
26. X. Niu Detectability of perfusion defect in five-dimensional gated-dynamic cardiac SPECT images Med. Phys. 37 2010 5102 5112
27. W. Hauser Technetium-99m DTPA: a new radiopharmaceutical for brain and kidney scanning Radiology 94 1970 679 684
28. T.H. Lin A 99mTc chelate substitute for organ radiomercurial renal agents J. Nucl. Med. 15 1970 34 35
29. A.R. Fritzberg Synthesis and biological evaluation of technetium-99m-MAG 3 as a hippuran replacement J. Nucl. Med. 27 1986 111 116 (Pubitemid 17023179)
30. M.D. Loberg Development of new radiopharmaceuticals based on N-substitution of iminodiacetic acid J. Nucl. Med. 17 1976 633 638
31. P.S. Callery Tissue distribution of technetium-99m and carbon-14 labeled N-(2,6 dimethylphenylcarbamylmethyl)imino-diacetic acid J. Med. Chem. 19 1976 962 964
32. H.D. Burns Improved synthesis of N(2,6-dimethylphenylcarbamoylmethyl) iminodiacetic acid and analogs J. Pharm. Sci. 67 1978 1434 1436 (Pubitemid 9031073)
33. G. Subramanian, and J.G. McAfee A new complex of 99mTc for skeletal imaging Radiology 99 1971 192 196
34. G. Subramanian 99mTc-labeled polyphosphate as a skeletal imaging agent Radiology 102 1972 701 704
35. G. Subramanian Technetium-99m-methylene diphosphonate - a superior agent for skeletal imaging: comparison with other technetium complexes J. Nucl. Med. 16 1975 744 755
36. R.D. Neirinckx Technefium-99m d,I-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion J. Nucl. Med. 28 1987 191 202 (Pubitemid 17025729)
37. R.D. Neirinckx The retention mechanism of 99mTc-HMPAO; intracellular reaction with glutathione J. Cereb. Blood Flow Metab. 8 1988 S4 S12
38. C. Roth The effect of ligand structure on glutathione-mediated decomposition of propylene amine oxime derivatives Int. J. Radiat. Appl. Instrum. B 19 1992 783 790
39. S. Vallabhajosula Technetium-99m ECD: a new brain imaging agent: in vivo kinetics and biodistribution studies in normal human subjects J. Nucl. Med. 30 1989 599 604 (Pubitemid 19140252)
40. M.L. Middleton, and M.D. Strober Planar scintigraphic imaging of the gastrointestinal tract in clinical practice Semin. Nucl. Med. 42 2012 33 40
41. H.F. Kung, and K. Ploessl [99mTc]TRODAT: dopamine transporter imaging agent for SPECT M.J. Welch, W.C. Eckelman, Targeted Molecular Imaging 2012 CRC Press 253 262
42. N. Kokudo Clinical application of TcGSA Nucl. Med. Biol. 30 2003 845 849 (Pubitemid 38040993)
43. K. Vernon Combined analysis of phase III trials evaluating [99mTc]tilmanocept and vital blue dye for identification of sentinel lymph nodes in clinically node-negative cutaneous melanoma Ann. Surg. Oncol. 20 2013 680 688
44. A.M. Wallace Lymphoseek: a molecular imaging agent for melanoma sentinel lymph node mapping Ann. Surg. Oncol. 14 2007 913 921 (Pubitemid 46175343)
45. A. Signore, and A.W. Glaudemans The molecular imaging approach to image infections and inflammation by nuclear medicine techniques Ann. Nucl. Med. 25 2011 681 700
46. S. Dizdarevic, and A.M. Peters Imaging of multidrug resistance in cancer Cancer Imaging 1 2011 1 8
47. K.A. Stephenson Bridging the gap between in vitro and in vivo imaging: isostructural Re and 99mTc complexes for correlating fluorescence and radioimaging studies J. Am. Chem. Soc. 126 2004 8598 8599 (Pubitemid 38955693)
48. S.R. Banerjee Synthesis and evaluation of technetium-99m- and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA) J. Med. Chem. 51 2008 4504 4517
49. K.P. Maresca Small molecule inhibitors of PSMA incorporating technetium-99m for imaging prostate cancer: effects of chelate design on pharmacokinetics Inorg. Chim. Acta 389 2012 168 175
50. 99mTc/Re-labeled small molecule prostate specific membrane antigen inhibitors with novel polar chelates Bioorg. Med. Chem. Lett. 23 2013 1557 1563
51. J.A. Barrett First-in-man evaluation of two high affinity PSMA-avid small molecules for imaging prostate cancer J. Nucl. Med. 54 2013 380 387
52. S.M. Hillier 123I-MIP-1072, a small-molecule inhibitor of prostate-specific membrane antigen, is effective at monitoring tumor response to taxane therapy J. Nucl. Med. 52 2011 1087 1093
53. + lisinopril complexes for in vivo imaging of angiotensin-converting enzyme expression J. Nucl. Med. 49 2008 970 977 (Pubitemid 351793438)
54. K.P. Maresca Novel polar single amino acid chelates for technetium-99m tricarbonyl-based radiopharmaceuticals with enhanced renal clearance: application to octreotide Bioconjug. Chem. 21 2010 1032 1042
55. G. Lu Synthesis and SAR of novel Re/99mTc-labeled benzenesulfonamide carbonic anhydrase IX inhibitors for molecular imaging of tumor hypoxia J. Med. Chem. 56 2013 510 520
56. P. Slobbe PET imaging with small-molecule tyrosine kinase inhibitors: TKI-PET Drug Discov. Today 17 2012 1175 1187
57. P.M. Mitrasinovic Some implications of receptor kinase signaling pathway for development of multitargeted kinase inhibitors Curr. Radiopharm. 6 2013 48 55
58. Cachovan Quantification of 99mTc-DPD concentration in the lumbar spine with SPECT/CT EJNMMI Res 3 2013 45 10.1186/2191-219X-3-45
59. A. Mahmood, and W.C. Eckelman Obituary Alun G Jones PhD, 1941-2012 Nucl. Med. Biol. 40 2013 1 2